These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33928584)

  • 1. Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.
    Tuttolomondo M; Ditzel HJ
    Methods Mol Biol; 2021; 2282():353-376. PubMed ID: 33928584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Penetrating Peptides Delivering siRNAs: An Overview.
    Falato L; Gestin M; Langel Ü
    Methods Mol Biol; 2021; 2282():329-352. PubMed ID: 33928583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
    Li H; Zheng X; Koren V; Vashist YK; Tsui TY
    Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTD/CPP peptide-mediated delivery of siRNAs.
    Presente A; Dowdy SF
    Curr Pharm Des; 2013; 19(16):2943-7. PubMed ID: 23140460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.
    van Asbeck AH; Beyerle A; McNeill H; Bovee-Geurts PH; Lindberg S; Verdurmen WP; Hällbrink M; Langel U; Heidenreich O; Brock R
    ACS Nano; 2013 May; 7(5):3797-807. PubMed ID: 23600610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Visible Nanovehicle for Efficient siRNA Delivery.
    Jin R; Zhu W; Lin G; Liu G; Ai H
    Methods Mol Biol; 2021; 2282():195-208. PubMed ID: 33928578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
    Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
    Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
    Nakase I; Tanaka G; Futaki S
    Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
    Dohmen C; Wagner E
    Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake Mechanism and Direct Translocation of a New CPP for siRNA Delivery.
    Pan R; Xu W; Ding Y; Lu S; Chen P
    Mol Pharm; 2016 Apr; 13(4):1366-74. PubMed ID: 26937821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.
    Ezzat K; Zaghloul EM; El Andaloussi S; Lehto T; El-Sayed R; Magdy T; Smith CI; Langel U
    J Control Release; 2012 Aug; 162(1):1-8. PubMed ID: 22698942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Liu Y
    Int J Pharm; 2016 Jun; 506(1-2):158-73. PubMed ID: 27106526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal and magnetic dual-responsive liposomes with a cell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy.
    Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Yang Y; Liu Y; Mei X
    Colloids Surf B Biointerfaces; 2016 Oct; 146():607-15. PubMed ID: 27429294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Nanoparticle Assisted Self-assembly of Cell Penetrating Peptides-Oligonucleotides Complexes for Gene Delivery.
    Dowaidar M; Abdelhamid HN; Hällbrink M; Freimann K; Kurrikoff K; Zou X; Langel Ü
    Sci Rep; 2017 Aug; 7(1):9159. PubMed ID: 28831162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
    Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
    Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
    Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
    J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.